BELLE HEALTH AI TECHNOLOGIES LTD 15705821 2024-05-07 2025-05-31 2025-05-31 WeFile 1.0 2026-10-26 General trading false true 0 0 8443 0 15175 200 0 0 0 15705821 2024-05-07 2025-05-31 15705821 2025-05-31 15705821 uk-gaap:AfterOneYear 2025-05-31 15705821 uk-gaap:SharePremium 2025-05-31 15705821 uk-gaap:CapitalRedemptionReserve 2025-05-31 15705821 uk-gaap:RetainedEarningsAccumulatedLosses 2025-05-31 15705821 2024-05-07 15705821 uk-bus:Director1 2024-05-07 2025-05-31 15705821 uk-bus:Micro-entities 2024-05-07 2025-05-31 15705821 uk-bus:PrivateLimitedCompanyLtd 2024-05-07 2025-05-31 15705821 uk-bus:FilletedAccounts 2024-05-07 2025-05-31 15705821 uk-bus:AuditExempt-NoAccountantsReport 2024-05-07 2025-05-31 iso4217:GBP xbrli:pure
BELLE HEALTH AI TECHNOLOGIES LTD
Company Registration Number
15705821
(England and Wales)

Unaudited Micro-Entity Accounts AMENDED
For the period 7 May 2024 to 31 May 2025

Prepared in accordance with the micro-entity provisions
of the Companies Act 2006 and FRS 105
BELLE HEALTH AI TECHNOLOGIES LTD

Contents

Balance Sheet3
Statement of Compliance4
Notes to the Financial Statements5–8
Amended Accounts Statement9
BELLE HEALTH AI TECHNOLOGIES LTD

Balance Sheet

As at 31 May 2025

2025
£
Fixed assets 8,443
Current assets 15,175
Creditors: amounts falling due within one year (19,580)
Net current assets (liabilities) (4,405)
Total assets less current liabilities 4,038
Total net assets (liabilities) 4,038
Capital and reserves 4,038
BELLE HEALTH AI TECHNOLOGIES LTD

Balance Sheet Continued

For the period ended 31 May 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The directors have elected not to deliver a copy of the profit and loss account to the registrar, in accordance with section 444(5A) of the Companies Act 2006.

Directors' responsibilities:

These amended accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

The accounts were approved by the Board of Directors and authorised for issue on 26 October 2026.

Rafael Schaider Bastos
Director
BELLE HEALTH AI TECHNOLOGIES LTD

Notes to the Financial Statements

For the period 7 May 2024 to 31 May 2025

1. Accounting Policies

Turnover

Turnover is recognised when goods are delivered or services are provided.

Taxation

Corporation tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Debtors

Debtors are recognised at the settlement amount due.

Cash at bank and in hand

Cash at bank and in hand includes cash and short term highly liquid investments.

Creditors

Creditors are recognised when there is an obligation at the balance sheet date as a result of a past event.

BELLE HEALTH AI TECHNOLOGIES LTD

Notes to the Financial Statements (continued)

2. Basis of Preparation

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

BELLE HEALTH AI TECHNOLOGIES LTD

Notes to the Financial Statements (continued)

3. Employee Information

The average number of employees during the period was: 0

Advances and credits to directors

Included within creditors falling due within one year is £18,467 owed to the directors.

BELLE HEALTH AI TECHNOLOGIES LTD

Notes to the Financial Statements (continued)

4. Amended accounts

These are amended accounts. They replace the original accounts for the period ended 31 May 2025, which were delivered to Companies House on 27 January 2026. The original accounts did not include the corporation tax liability of £1,113.02 for the period and used provisional figures for some balances. These amended accounts use the final figures and include the tax in creditors due within one year. Net assets are £4,037.76 (originally £5,169).

BELLE HEALTH AI TECHNOLOGIES LTD

Notes to the Financial Statements (continued)

Amended Accounts Statement

These revised accounts replace the accounts previously filed for the period ended 31 May 2025.

These accounts are now the statutory accounts for the period.

These revised accounts have been prepared as at 23 January 2026, the date of approval of the original accounts, and not as at the date of revision. Accordingly, they do not deal with events between those dates.

Respects in which the previously filed accounts did not comply with the Companies Act 2006:

The original accounts did not include the corporation tax liability of £1,113.02 for the period and used provisional figures for some balances.

Significant amendments made:

Corporation tax of £1,113.02 added to creditors due within one year. Fixed assets, current assets and creditors updated to the final figures. Net assets are now £4,037.76 (originally £5,169).

Date of approval of revision: 26 October 2026